EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Hydrogen‐Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self‐Sustaining Catalytic Immunotherapy

Mingfan Shi, Jingrui Cao, Tong Wu, Guang Yang, YaWen Yang, Shixin Zhang, Wenwen Su, Hongyu Chu, Yangyang Zhao, Shan Jiang, Qiong Wu, Dongxu Jiao und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202524313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Mingfan Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology Nanomedicine and Translational Research Center, Ministry of Education, China-Japan Union Hospital of Jilin University,…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Hydrogen, Mitochondria, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of nanocatalytic therapy is constrained by the limited availability of endogenous hydrogen peroxide (H 2 O 2 ) as a reaction substrate, finite catalytic activity of nanozymes and rapid scavenging by intracellular antioxidants, hindering their accumulation at target sites to therapeutic concentrations. To address the core bottleneck, we developed a hydrogen‐doped rhodium‐palladium alloy (RhPd‑H) nanozyme that integrates enhanced peroxidase (POD)‐mimetic catalytic activity with thermally triggered hydrogen gas (H 2 ) release. Under near‐infrared (NIR) irradiation, the RhPd‐H performs POD activity to efficiently produce exogenous hydroxyl radicals (·OH), inducing initial oxidative stress. Concurrently, the released H 2 flux could reduce the level of reactive oxygen species (ROS) within mitochondria, thereby mitigating oxidative damage and reprogramming mitochondria into endogenous ROS generator that continuously leak superoxide anion (·O 2 − ). This dual‐path ROS generation mechanism sustains prolonged intracellular ROS burst to efficiently kill tumor cells. Further, in vivo evaluations demonstrated that RhPd‐H nanoenzyme exhibited long‐term tumor retention, significant suppression of tumor growth and activation of antitumor immunity. By differentially regulating ROS across space and time, RhPd‑H nanozyme establishes a persistent and overwhelming oxidative stress that effectively disrupts redox homeostasis. Our work advances beyond conventional catalytic therapy, proposing a new concept of metabolically amplified nanozyme therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesHydrogenMitochondriaImmunotherapyAnimalsPalladiumMiceHumansCatalysisRhodiumOxidative StressCell Line, TumorHydrogen Peroxide

Stichwörter der Autor:innen

Pd‐based alloy nanohydrideshydrogen‐releasing nanozymemitochondrial reprogrammingprolonged oxidative stresstumor catalytic therapy

Substanzen

Reactive Oxygen SpeciesHydrogenPalladiumRhodiumHydrogen Peroxide

Autor:innen und Institutionen

  • Key Laboratory of Pathobiology Nanomedicine and Translational Research Center, Ministry of Education, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
  • Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang Province, China.
  • The First Research Laboratory, Changchun Institute of Biological Products Co., Ltd., Changchun, Jilin, China.
  • JILIN Cancer Hospital, Changchun, Jilin, China.
  • Department of Gastrointestinal, Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
  • College of Chemistry Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin, China.

ORCID-Profile: Fangfang Chen

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province
  • China-Japan Union Hospital of Jilin University MED+X Interdisciplinary Discipline Cultivation Program
  • Program for Jilin University Science and Technology Innovative Research Team

Zitieren

APA

Shi, M., Cao, J., Wu, T., Yang, G., Yang, Y., Zhang, S., Su, W., Chu, H., Zhao, Y., Jiang, S., Wu, Q., Jiao, D., & Chen, F. (2026). A Hydrogen‐Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self‐Sustaining Catalytic Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202524313

Vancouver

Shi M, Cao J, Wu T, Yang G, Yang Y, Zhang S, et al. A Hydrogen‐Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self‐Sustaining Catalytic Immunotherapy. Advanced Science. 2026. doi:10.1002/advs.202524313

BibTeX
@article{Shi2026,
  author = {Shi, Mingfan and Cao, Jingrui and Wu, Tong and Yang, Guang and Yang, YaWen and Zhang, Shixin and Su, Wenwen and Chu, Hongyu and Zhao, Yangyang and Jiang, Shan and Wu, Qiong and Jiao, Dongxu and Chen, Fangfang},
  title = {A Hydrogen‐Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self‐Sustaining Catalytic Immunotherapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202524313}
}
Kostenlos starten →